Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04609514 · ClinicalTrials.gov registry record · NA
Learn to Quit-HIV Pilot Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT04609514 is a NA study that has completed, run by Duke University. The registered enrollment target is 51 participants.
The verdict
NCT04609514, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.
Interventions
- DRUG Nicotine patch
- BEHAVIORAL QuitGuide
- DEVICE Learn to Quit-HIV
- BEHAVIORAL Smartphone coaching
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-01-25 |
| Est. Completion | 2022-06-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04609514
The ClinicalTrials.gov registry entry for NCT04609514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nicotine patch is the first listed.
NCT04609514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04609514 about?
NCT04609514 is a clinical study titled "Learn to Quit-HIV Pilot Study". The study team will conduct a feasibility, acceptability, and preliminary efficacy trial comparing Learn to Quit-HIV (n=30) to an app based on U.S. Clinical Practice Guidelines only (NCI QuitGuide; n=30) among HIV-positive smokers. Both apps will be integrated with NRT and ongoing HIV clinical care.
What is the current status of trial NCT04609514?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2021-01-25. Estimated completion is 2022-06-02.
What interventions are being tested in trial NCT04609514?
The interventions under investigation include: Nicotine patch (DRUG), QuitGuide (BEHAVIORAL), Learn to Quit-HIV (DEVICE), Smartphone coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT04609514?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.